Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67591193
Model No.: 874819-74-6
Brand: DM
Grade Standard: Medicine Grade
Type: Analysis reagent
State: Solid
Volatile: Not Volatile
Packaging: double PE with aluminium foil bag
Productivity: 100kg/month
Transportation: Ocean,Air
Place of Origin: Hebei,China
Supply Ability: 100kg/month
Certificate: ISO9001
Port: Shanghai
Payment Type: L/C,T/T,Paypal
Incoterm: FOB,CIF
Color: orange powder
Toceranib. It is marketed as Palladia as its phosphate salt, toceranib phosphate ( INN) by Pfizer. It wasdeveloped by SUGEN as SU11654, a sister compound to sunitinib, which was later approved for humantherapies. Toceranib is likely to act mostly through inhibition of the kit tyrosine kinase, though it may alsohave an anti-angiogenic effect.
* Toceranib Phosphate. Anticancer agent. For treatment of Grade II or III cutaneousmast cell tumors...
* Oncology. Brooke Fowler, ... Tyrosine kinases are proteins expressed on cellsurfaces...
* Clinical Trials and Developmental Therapeutics.
* Chemotherapy. Adjuvant therapy for gastrointestinal cancer, particularly gastric, pancreatic
ITEMS SPECIFICATION RESULTS Appearance Orange powder Orange powder Purity ≥97.0% 99.12% HNMR Passed Storage Sealed and stored in a dry place at room temperature. Conclusion: Complies with Standard.
Product Categories : APIs And Intermediates > APIs Powder
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Contact Now